SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-21-018177
Filing Date
2021-04-08
Accepted
2021-04-08 16:16:15
Documents
7
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A rgnx-pre14a_20210604.htm PRE 14A 1620134
2 GRAPHIC g4as0fshz1ic000006.jpg GRAPHIC 267336
3 GRAPHIC g4as0fshz1ic000005.jpg GRAPHIC 606083
4 GRAPHIC g4as0fshz1ic000002.jpg GRAPHIC 3038
5 GRAPHIC g4as0fshz1ic000001.jpg GRAPHIC 21687
6 GRAPHIC g4as0fshz1ic000004.jpg GRAPHIC 112074
7 GRAPHIC g4as0fshz1ic000003.jpg GRAPHIC 29686
  Complete submission text file 0001564590-21-018177.txt   3053557
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37553 | Film No.: 21815099
SIC: 2836 Biological Products, (No Diagnostic Substances)